NCT06241781: Autologous Tumor Infiltrating Lymphocytes Injection (GT101 Injection) for the Treatment of Recurrent or Metastatic Cervical Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 100 planned
- Started
- 2 Apr 2024
- Primary completion
- 31 Jan 2027
- Arms
- GT101 treatment group
- Results
- None posted
- 5 Feb 2024: Trial registered
- 2 Apr 2024: Trial started